Fact Based List:

The 10 drugs for which companies spent the most in payments to physicians in 2015

  1. Xarelto ($28.4 Million)
  2. Humira ($24.9 Million)
  3. Invokana ($20.9 Million)
  4. Viekira ($19.2 Million)
  5. Eliquis ($18.8 Million)
  6. Bydureon ($18.5 Million)
  7. Androgel ($15.3 Million)
  8. Synthroid ($14.7 Million)
  9. Lupron ($14.3 Million)
  10. Victoza ($11.9 Million)

Source: Pro Publica
Source URL: https://www.propublica.org/article/updated-dollars-for-docs-...